Sara Ramaker

Statistics

Publications

Citations

H-Index

Active since

2014

Affiliations

Sara Ramaker is an author at Pfizer (United States) specializing in pediatric psychopharmacology, antidepressant pharmacotherapy, and psychopharmacology.

ORCID

Publications per year

2014–2017

Publications

Desvenlafaxine Versus Placebo in a Fluoxetine-Referenced Study of Children and Adolescents with Major Depressive Disorder

Karen L. Weihs, William G. Murphy, Richat Abbas et al. · Journal of Child and Adolescent Psychopharmacology · 2017 · 44 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Desvenlafaxine Versus Placebo in the Treatment of Children and Adolescents with Major Depressive Disorder

Sarah Atkinson, Shannon L. Lubaczewski, Sara Ramaker et al. · Journal of Child and Adolescent Psychopharmacology · 2017 · 34 citations · Full text

Medicine, Pharmacology, Psychiatry +17

Safety and Tolerability of Desvenlafaxine in Children and Adolescents with Major Depressive Disorder

Robert L. Findling, James Groark, Deborah Chiles et al. · Journal of Child and Adolescent Psychopharmacology · 2014 · 17 citations · Full text

Medicine, Pharmacology, Psychiatry +17

1–3 of 3